|
|
Volumn 6, Issue 2, 2005, Pages 68-
|
|
COX-2 inhibitors: Cancer prevention or cardiovascular risk?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
NITRIC OXIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PLACEBO;
ROFECOXIB;
ADENOMA;
ADENOMATOUS POLYP;
ARTHRITIS;
BREAST CANCER;
CANCER;
CANCER PREVENTION;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
COLORECTAL CANCER;
DEMENTIA;
DOSE RESPONSE;
DRUG DESIGN;
DRUG RESEARCH;
DRUG WITHDRAWAL;
HEART INFARCTION;
HUMAN;
NOTE;
PRIORITY JOURNAL;
THROMBOSIS;
ADENOMA;
CARDIOVASCULAR DISEASES;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
HUMANS;
LACTONES;
MEMBRANE PROTEINS;
NEOPLASMS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PYRAZOLES;
RANDOMIZED CONTROLLED TRIALS;
SULFONAMIDES;
SULFONES;
|
|
EID: 13344268903
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(05)01720-1 Document Type: Note |
|
Times cited : (12)
|
|
References (0)
|